XOMA 052 Mab | XOMA 629 | RAPTIVA® | HCD122 Mab
	Pipeline
	PROPRIETARY XOMA 052   T2D   RA   SJIA   Gout   Others XOMA 629 (Superficial skin infections) Biodefense (Anti-bot. Ab) OTHER PRECLINICAL PARTNERED & LICENSED RAPTIVA® (Genentech, Merck Serono) HCD122 (Novartis)   MM   CLL   Other B Cell Cancers Other Oncology (Novartis) Metabolic Disease (Lexicon) Undisclosed Targets (Schering-Plough,Takeda) LUCENTIS® (Genentech, Novartis) CIMZIA™ (UCB) OTHER BCE™ (More than 50 Licenses) VARIOUS STAGES